Structure Therapeutics Inc. (GPCR)
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.
$2.15B
Dr. Raymond C. Stevens Ph.D.
South San Francisco, CA
Feb 03, 2023
-17.69
$-2.19
16.84
41.38
-7,562.14%
-18.89
-0.19
2.06
1,720.23
41.38
-10.62%
-20.15%
Similar stocks (11)
Morphic Holding, Inc.
MORF
Disc Medicine, Inc.
IRON
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
Inozyme Pharma, Inc.
INZY
Biomea Fusion, Inc.
BMEA
Amylyx Pharmaceuticals, Inc.
AMLX
HOOKIPA Pharma Inc.
HOOK
Acumen Pharmaceuticals, Inc.
ABOS
X4 Pharmaceuticals, Inc.
XFOR
Eledon Pharmaceuticals, Inc.
ELDN
ETF Exposure (11)
TrueShares Technology, AI and Deep Learning ETF
LRNZ
3.7%
First Trust Multi-Manager Small Cap Opportunities ETF
MMSC
0.44%
Vanguard Health Care Fund Admiral Shares
VGHAX
0.31%
Vanguard Health Care Fund
VGHCX
0.31%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.183%
iShares Biotechnology ETF
IBB
0.16502%
BlackRock Future Health ETF
BMED
0.13147%
SPDR S&P Emerging Markets Small Cap ETF
EWX
0.061029%
ProShares Ultra Nasdaq Biotechnology
BIB
0.054214612042262786%
SPDR S&P China ETF
GXC
0.020652%
Fidelity Nasdaq Composite Index ETF
ONEQ
0.01%
Similar stocks (11)
Morphic Holding, Inc.
MORF
Disc Medicine, Inc.
IRON
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
Inozyme Pharma, Inc.
INZY
Biomea Fusion, Inc.
BMEA
Amylyx Pharmaceuticals, Inc.
AMLX
HOOKIPA Pharma Inc.
HOOK
Acumen Pharmaceuticals, Inc.
ABOS
X4 Pharmaceuticals, Inc.
XFOR
Eledon Pharmaceuticals, Inc.
ELDN
ETF Exposure (11)
TrueShares Technology, AI and Deep Learning ETF
LRNZ
3.7%
First Trust Multi-Manager Small Cap Opportunities ETF
MMSC
0.44%
Vanguard Health Care Fund Admiral Shares
VGHAX
0.31%
Vanguard Health Care Fund
VGHCX
0.31%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.183%
iShares Biotechnology ETF
IBB
0.16502%
BlackRock Future Health ETF
BMED
0.13147%
SPDR S&P Emerging Markets Small Cap ETF
EWX
0.061029%
ProShares Ultra Nasdaq Biotechnology
BIB
0.054214612042262786%
SPDR S&P China ETF
GXC
0.020652%
Fidelity Nasdaq Composite Index ETF
ONEQ
0.01%